Diabetes

NDA submission deadline extended

The NDA has extended the deadline for audit submissions until the 30th October 2009. This is in response to requests from both primary and secondary care, who have additional commitments on their time during this period.

About the audit

The National Diabetes Audit (NDA) is developed and delivered by National Clinical Audit Support Programme (NCASP), which is part of The Information Centre. The NDA was commissioned and sponsored by the Healthcare Commission. Commissioning of this, and other National Clinical Audit and Patient Outcome Programme projects, transferred to the Healthcare Quality Improvement Partnership (HQIP) from 1st April 2008.

The NDA is considered to be the largest annual clinical audit in the world. It provides an infrastructure for the collation, analysis, benchmarking and feedback of local clinical data to support effective clinical audit across the NHS.

Quality information is vital to the success of organisations implementing the Diabetes National Service Framework (NSF) and key to improving services for people with diabetes. The NDA supports the implementation of the diabetes NSF and aims to improve the quality of patient care by enabling NHS organisations to:

  • compare the processes and outcomes of care with similar NHS organisations
  • identify and share good practice
  • identify gaps or shortfalls in commissioning services
  • support identification of progress in meeting Diabetes NSF and NICE guidelines
  • provide a local health economy view of care and outcomes where primary and secondary care organisations actively participate.

Partnerships

The National Diabetes Audit works in partnership with the following groups:


Design & Technology by Precedent